EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts

Maja Schlittler iD, Peter P Pramstaller, Alessandra Rossini iD, Marzia De Bortoli iD

International Journal of Molecular Sciences · 02.10.2023 · 24 (19) · 14845

DOI: 10.3390/ijms241914845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.10.2023. Verfasst von Maja Schlittler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eurac Research, Institute for Biomedicine (Affiliated to the University of Lübeck), 39100 Bolzano, Italy. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Autonomous Province of Bolzano/ Bozen South Tyrol in the framework of the Programme, Autonomous Province of Bolzano/ Bozen South Tyrol, Department of Innovation, Research and University of the Autonomous Province of Bolzano, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and the leading cause of sudden cardiac death in young people. Mutations in genes that encode structural proteins of the cardiac sarcomere are the more frequent genetic cause of HCM. The disease is characterized by cardiomyocyte hypertrophy and myocardial fibrosis, which is defined as the excessive deposition of extracellular matrix proteins, mainly collagen I and III, in the myocardium. The development of fibrotic tissue in the heart adversely affects cardiac function. In this review, we discuss the latest evidence on how cardiac fibrosis is promoted, the role of cardiac fibroblasts, their interaction with cardiomyocytes, and their activation via the TGF-β pathway, the primary intracellular signalling pathway regulating extracellular matrix turnover. Finally, we summarize new findings on profibrotic genes as well as genetic and non-genetic factors involved in the pathophysiology of HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicHumansAdolescentMyocardiumMyocytes, CardiacFibroblastsFibrosis

Stichwörter der Autor:innen

TGF-βcardiac fibroblasthypertrophic cardiomyopathymyocardial fibrosismyofibroblasts

Autor:innen und Institutionen

  • Eurac Research, Institute for Biomedicine (Affiliated to the University of Lübeck), 39100 Bolzano, Italy.

ORCID-Profile: Maja Schlittler, Alessandra Rossini, Marzia De Bortoli

Förderung

  • The Autonomous Province of Bolzano/ Bozen South Tyrol in the framework of the Programme
  • Autonomous Province of Bolzano/ Bozen South Tyrol
  • Department of Innovation, Research and University of the Autonomous Province of Bolzano, Italy

Zitieren

APA

Schlittler, M., Pramstaller, P. P., Rossini, A., & De Bortoli, M. (2023). Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts. International Journal of Molecular Sciences, 24(19), 14845. https://doi.org/10.3390/ijms241914845

Vancouver

Schlittler M, Pramstaller PP, Rossini A, De Bortoli M. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts. International Journal of Molecular Sciences. 2023;24(19):14845. doi:10.3390/ijms241914845

BibTeX
@article{Schlittler2023,
  author = {Schlittler, Maja and Pramstaller, Peter P and Rossini, Alessandra and De Bortoli, Marzia},
  title = {Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14845},
  doi = {10.3390/ijms241914845}
}
Kostenlos starten →